-

nihao guest [ sign in / register ]
2024-3-28 17:06:41
Article

Finkelstein DB, Mukatira S, Mehta PK, Obenauer JC,. Persistent Host Markers in Pandemic and H5N1 Influenza Viruses. J Virol. 2007 Jul 25.  Abstract  
submitted by kickingbird at Jul, 30, 2007 from J Virol. 2007 Jul 25 (via http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowD)
Avian influenza viruses have adapted to human hosts causing pandemics in humans. The key host-specific amino acid mutations required for an avian influenza virus to function in humans are unknown. Through ...

Tumpey TM, Szretter KJ, Van Hoeven N, Katz JM, Koc. The Mx1 gene protects mice against pandemic 1918 and highly lethal human H5N1 influenza viruses. J Virol. 2007 Jul 25.  Abstract  
submitted by kickingbird at Jul, 30, 2007 from J Virol. 2007 Jul 25 (via http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowD)
Mice carrying a wild-type Mx1 gene (Mx1(+/+)) differ from standard laboratory mice (Mx1(-/-)) in being highly resistant to infection with common laboratory strains of influenza A virus. We report that ...

Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):1247.  Abstract  
submitted by kickingbird at Jul, 30, 2007 from Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):1247 (via http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowD)
Because proinflammatory cytokines are markedly elevated during H5N1 influenza virus infection, the "cytokine storm" is hypothesized to be the main cause of mortality. Here, we demonstrate that mice deficient ...

Horimoto T, Murakami S, Muramoto Y, Yamada S, Fuji. Enhanced growth of seed viruses for H5N1 influenza vaccines. Virology. 2007 Jul 23.  Abstract  
submitted by kickingbird at Jul, 30, 2007 from Virology. 2007 Jul 23 (via http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowD)
Seed viruses used to produce inactivated H5N1 influenza vaccines are recombinant viruses with modified avirulent-type hemagglutinin (HA) and intact neuraminidase (NA) genes, both derived from an H5N1 isolate, ...

Lu J, Li Z, Cao YX, Wang Q, Wang XP, Huang JJ, Wan. Development of an enzyme-linked immunosorbent assay for the diagnosis of lethal avian influenza virus infection. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi..  Abstract  
submitted by kickingbird at Jul, 30, 2007 from Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. (via http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowD)
BACKGROUND: To establish a convenient method for diagnosis of lethal avian influenza virus infection. METHODS: Ninety-six-well microtiter plates were coated with 100 ul of H5N1 protein (0.1 g/ml) diluted ...

Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Tatusova. FLAN: a web server for influenza virus genome annotation.. Nucleic Acids Res. 2007 Jul 1;35.  Full Text  
submitted by kickingbird at Jul, 30, 2007 from Nucleic Acids Res. 2007 Jul 1;35 (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
FLAN (short for FLu ANnotation), the NCBI web server for genome annotation of influenza virus (http://www.ncbi.nlm.nih.gov/genomes/FLU/Database/annotation.cgi) is a tool for user-provided influenza A virus ...

Marsh GA, Hatami R, Palese P. SPECIFIC RESIDUES OF THE INFLUENZA A VIRUS HA vRNA ARE IMPORTANT FOR EFFICIENT PACKAGING INTO BUDDING VIRIONS. J Virol. 2007 Jul 18.  Abstract  
submitted by kickingbird at Jul, 25, 2007 from J Virol. 2007 Jul 18 (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
A final step in the influenza virus replication cycle is the assembly of the viral structural proteins and packaging of the eight segments of vRNA into a fully infectious virion. The process by which the ...

Joseph T, McAuliffe J, Lu B, Jin H, Kemble G, Subb. Evaluation of replication and pathogenicity of avian influenza A H7 subtype viruses in a mouse model. J Virol. 2007 Jul 18.  Abstract  
submitted by kickingbird at Jul, 25, 2007 from J Virol. 2007 Jul 18 (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
Avian influenza A H7 subtype viruses pose a significant threat to human health because of their ability to transmit directly from domestic poultry to humans and to cause disease and sometimes death. Although ...

Chowell G, Miller MA, Viboud C. Seasonal influenza in the United States, France, and Australia: transmission and prospects for control. Epidemiol Infect. 2007 Jul 18;:1-13.  Abstract  
submitted by kickingbird at Jul, 25, 2007 from Epidemiol Infect. 2007 Jul 18;:1-13 (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
SUMMARY:Recurrent epidemics of influenza are observed seasonally around the world with considerable health and economic consequences. A key quantity for the control of infectious diseases is the reproduction ...

AUEWARAKUL P, Suptawiwat O, Kongchanagul A, Sangma. An avian influenza H5N1 virus that binds to human-type receptor. J Virol. 2007 Jul 11.  Abstract  
submitted by kickingbird at Jul, 19, 2007 from J Virol. 2007 Jul 11 (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
Avian influenza viruses preferentially recognize sialosugar chains terminating in sialic acid-alpha2,3-galactose (SAalpha2,3Gal), whereas human influenza viruses preferentially recognize SAalpha2,6Gal. ...

Noton SL, Medcalf E, Fisher D, Mullin AE, Elton D,. Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J Gen Virol. 2007 Aug;88(Pt 8):2280-90.  Abstract  
submitted by kickingbird at Jul, 19, 2007 from J Gen Virol. 2007 Aug;88(Pt 8):2280-90 (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
The matrix (M1) protein of influenza A virus is a multifunctional protein that plays essential structural and functional roles in the virus life cycle. It drives virus budding and is the major protein ...

Betakova T, Hay AJ.. Evidence that the CM2 protein of influenza C virus can modify the pH of the exocytic pathway of transfected cells. J Gen Virol. 2007 Aug;88(Pt 8):2291-6..  Abstract  
submitted by kickingbird at Jul, 19, 2007 from J Gen Virol. 2007 Aug;88(Pt 8):2291-6. (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
The 115 residue CM2 protein of influenza C virus is a structural homologue of the M2 protein of influenza A virus. Expression of the CM2 protein in Xenopus oocytes showed that it can form a voltage-activated ...

DUCATEZ MF, Olinger CM, Owoade AA, Tarnagda Z, et. Molecular and antigenic evolution and geographical spread of H5N1 highly pathogenic avian influenza viruses in western Africa. J Gen Virol. 2007 Aug;88(Pt 8):2297-306..  Abstract  
submitted by kickingbird at Jul, 19, 2007 from J Gen Virol. 2007 Aug;88(Pt 8):2297-306. (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
In Africa, highly pathogenic avian influenza H5N1 virus was first detected in northern Nigeria and later also in other regions of the country. Since then, seven other African countries have reported H5N1 ...

Anthony E. Fiore., etc.,al. Prevention and Control of Influenza. MMWR.  Full Text  
submitted by kickingbird at Jul, 13, 2007 from MMWR (via http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5606a1.htm?s_cid=)
This report updates the 2006 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: ...

PARKS CL, Latham T, Cahill A, O´neill RE, et. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain. Virology. 2007 Jun 27.  Abstract  
submitted by kickingbird at Jul, 12, 2007 from Virology. 2007 Jun 27 (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
Widespread use of a live-attenuated influenza vaccine (LAIV) in the United States (licensed as FluMist) raises the possibility that vaccine viruses will contribute gene segments to the type A influenza ...

Redlberger M, Aberle SW, Heinz FX, Popow-Kraupp T. Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/2005) in Austria. Vaccine. 2007 Jun 11.  Abstract  
submitted by kickingbird at Jul, 12, 2007 from Vaccine. 2007 Jun 11 (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
Human influenza viruses are subject to continuous antigenic drift and this phenomenon poses great problems for the annual production of vaccines which should ideally be manufactured from strains closely ...

ABDEL-MOTAL UM, Guay HM, Wigglesworth K, Welsh RM,. Increased immunogenicity of influenza virus vaccine by anti-Gal mediated targeting to antigen presenting cells. J Virol. 2007 Jul 3.  Abstract  
submitted by kickingbird at Jul, 12, 2007 from J Virol. 2007 Jul 3 (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
This study describes a method for increasing immunogenicity of influenza virus vaccines by exploiting the natural anti-Gal antibody for effective targeting vaccines to antigen presenting cells (APC). This ...

KAWAI N, Ikematsu H, Iwaki N, Kawashima T, et al. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. J Infect. 2007 Jun 29.  Abstract  
submitted by kickingbird at Jul, 12, 2007 from J Infect. 2007 Jun 29 (via http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=Pub)
OBJECTIVE: To compare the persistence, susceptibility and resistance of influenza A and influenza B viruses in oseltamivir therapy in outpatients of various ages. METHODS: Virus isolation was done before ...

CSR. Infection prevention and control of epidemic- and pandemic-prone acute respiratory diseases in health care. WHO.  Full Text  
submitted by kickingbird at Jul, 11, 2007 from WHO (via http://www.who.int/csr/resources/publications/WHO_CD_EPR_200)
WHO/CDS/EPR/2007.6 WHO Interim Guidelines June 2007Full text (English)- [pdf 2.68Mb] Guidance updates The present guidelines supersede the document "Hospital Infection Control Guidance for Severe ...

Ozawa M, Goto H, Horimoto T, Kawaoka Y. An Adenoviral Vector-Mediated Reverse Genetics System for Influenza A Virus Generation. J Virol. 2007 Jun 27.  Abstract  
submitted by kickingbird at Jul, 5, 2007 from J Virol. 2007 Jun 27 (via http://www.ncbi.nlm.nih.gov/sites/entrez?tmpl=NoSidebarfile&)
Plasmid-based reverse genetics systems allow the generation of influenza A virus entirely from cloned cDNA. However, since the efficiency of virus generation is dependent on the plasmid transfection efficiency ...

7429 items, 20/Page, Page[310/372][|<<] [|<] [301] [302] [303] [304] [305] [306] [307] [308] [309] [310] [>|] [>>|]

Related Pages:

Browse by Category
Learn about the flu news, articles, events and more
Subscribe to the weekly F.I.C newsletter!


  

Site map  |   Contact us  |  Term of use  |  FAQs |  粤ICP备10094839号-1
Copyright ©www.flu.org.cn. 2004-2024. All Rights Reserved. Powered by FIC 4.0.1
  Email:webmaster@flu.org.cn